Why is Morepen Labs. falling/rising?

As of 08-Sep, Morepen Laboratories Ltd is experiencing a slight decline in its stock price, currently at 49.24, down by 0.07 or 0.14%. The stock has been losing value for the last three days, with a total drop of 1.68% during this period. Although the stock has shown a positive return of 2.22% over the past week and 4.37% over the past month, it has significantly underperformed over the longer term, with a year-to-date decline of 37.11% and a one-year drop of 44.88%. The company has reported negative results in recent quarters, with a notable fall in net sales and profits, which has contributed to a lack of investor confidence, as evidenced by a 33.14% decrease in delivery volume compared to the five-day average. In the broader market context, while the Sensex has gained 0.53% over the past week and 1.16% over the past month, Morepen Laboratories Ltd's short-term performance has been relatively weak. The stock's liquidity remains adequate, but the lack of domestic mutual fund investment suggests a cautious sentiment towards the company. The stock's poor long-term growth prospects, highlighted by a decline in net sales and consecutive negative quarterly results, further exacerbate its underperformance compared to the benchmark indices. Overall, the combination of negative financial results, declining investor participation, and poor long-term growth outlook has led to the stock's recent downward movement.